According to the Food Agriculture Organization of the United Nations (FAO), each year, plant diseases cost the world economy over €210 billion, and fungal infections damage at least one-third of all food crops. Commercial agriculture relies on chemical fungicides for crop protection, due to their low cost and ease of application; yet their widespread use…
Actualmente muchas empresas se ven influidas por la transformación digital del entorno de mercado en el cual operan y deben adaptarse a las nuevas realidades. En el caso de Inveniam, la irrupción de las tecnologías de Inteligencia Artificial (IA) impacta en muchos de sus procesos habituales de búsqueda de oportunidades innovadoras de base tecnológica en…
Lung cancer is the most lethal form of cancer globally, with five-year survival following diagnosis varying between 5% to 25%. Around 20% of lung cancer patients are “non-smokers,” indicating that there are other risk factors and determinants besides tobacco smoking that might contribute to the development of this disease. LUCIA is an interdisciplinary project that…
Mark your Are you interested in the latest innovations in the life sciences and healthcare industries? Do you want to discover promising startups and projects in the MedTech and BioTech fields? calendars for the Life Science Investment Readiness Series – Israel Edition, which is set to take place on May 16th, 2023, in Tel Aviv.…
Inveniam Group is made up of a diverse and multidisciplinary team that works together to bring breakthrough technologies to the market. Every month we will highlight one of our team members to get to know them and show who we are. For our 12th installment we feature our associate Miriam Romero. What interested you about working…
Inveniam Group is made up of a diverse and multidisciplinary team that works together to bring breakthrough technologies to the market. Every month we will highlight one of our team members to get to know them and show who we are. For our 11th installment we feature our founding partner, Elena Canetti, to celebrate inspiring women…
To kick off the Barcelona Health Innovation Week, Biocat presented the 2022 BioRegion Report, a benchmark study that analyses the life sciences and healthcare sector in Catalonia. In particular, the report demonstrates that Catalonia has been able to buck the macroeconomic trends and uncertainties to raise record levels of investment for innovation, particularly start ups.…
The UAB Barcelona, Biociencies UAN & VHIO are joining forces to open a new Master’s degree in Health and Science Management that provides graduate students, postdocs & professionals with a holistic view of the scientific management ecosystem and promotes the acquisition of the strategic vision and skills needed to become a well-rounded scientific manager. We…
Inveniam Group is made up of a diverse and multidisciplinary team that works together to bring breakthrough technologies to the market. Every month we will highlight one of our team members to get to know them and show who we are. For our 10th installment we present, Guillermo Llamas. What interested you about working with Inveniam…
Nimble Diagnostics has raised over €1 million in a round led by Grow Ventures and Namarel Ventures, with participation from Inveniam Group, who acted as a syndicate of various business angels. Nimble is a MedTech spin-off from the Health Science Research Germans Trias i Pujol Institute (IGTP), the Polytechnic University of Catalonia (UPC), and the…